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Abstract 
Primordial germ cells (PGCs), the precursors of sperm and eggs, are established in peri-
gastrulation stage-embryos in mammals. Signals from extraembryonic tissues induce a unique 
gene regulatory network in germline competent cells for PGC specification. This network also 
initiates comprehensive epigenome resetting, including global DNA demethylation and 
chromatin reorganization. Mouse germline development has been studied extensively, but the 
extent to which such knowledge applies to humans was unclear. Here, we review latest 
advances in human PGC specification and epigenetic reprogramming. Although the overall 
developmental dynamics of human and mouse germline appear similar, there are critical 
mechanistic differences in PGC specification, reflecting divergence in the regulation of 
pluripotency and early development. 
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Key Points 
• Regulation of pluripotency and early postimplantation embryonic development have 
diverged between human and mouse, which might affect the mechanism of primordial germ 
cell (PGC) specification. 
• Specification of human and mouse PGCs occurs in response to extrinsic signals, including 
BMP2/4. 
• Models of human PGC specification from pluripotent stem cells suggests that human PGCs 
originate from mesodermal precursors at the posterior epiblast during the onset of 
gastrulation, while mouse PGCs originate from pre-gastrulation epiblast. 
• The gene regulatory network for PGC specification and maintenance in humans and mice 
has diverged. Notably, SOX17, a key endoderm specifier, is also critical for PGC 
specification in humans but not in mice. 
• PGCs undergo genome-wide DNA demethylation which erases parental epigenetic 
memories and facilitates germ cell differentiation in humans and mice. 
• Repressive histone modifications might safeguard PGC genome stability during global DNA 
demethylation. 
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Introduction  
The germline provides the enduring link between all generations of an organism. In mammals, 
primordial germ cells (PGCs), the founder cells of the germline, are specified during early 
embryonic development. Thereafter, PGCs migrate to the developing gonads, where they 
undergo meiosis and differentiate into gametes. Fertilization of the oocyte by the sperm results 
in a totipotent zygote that gives rise to all lineages of an organism, including the germline itself. 
Thus, specification of PGC can be regarded as a crucial first step for the acquisition of 
totipotency and the continuation of the mammalian life cycle (Figure 1).  
Mouse is the primary mammalian model for investigations on germ cell development. Mouse 
primordial germ cell (mPGC) specification is initiated in the early postimplantation embryo that 
develops as an egg cylinder (Box 1). Bone morphogenetic protein (BMP) and WNT signals1 
from extraembryonic tissues induce expression of PRDM1 (also known as BLIMP1), the key 
regulator of PGC fate, in a few pluripotent epiblast cells at ~embryonic day (E) 6.252. This is 
followed by upregulation of two other key specification factors: PRDM143 and TFAP2C4. 
Thereafter, PRDM1, PRDM14 and TFAP2C form a core regulatory network that induces the 
germ cell fate5-7. At E7.25, a founder population of ~40 mPGCs are formed at the base of the 
allantois8, which subsequently migrate into the hindgut and colonize the genital ridge by E11.5. 
To erase somatic epigenetic memories, migratory mPGCs undergo genome-wide epigenetic 
reprogramming, which entails global DNA demethylation9-11, imprint erasure12, 13, X-chromosome 
reactivation14-17 and reorganisation of chromatin modifications18, 19. These epigenetic changes 
are attained by ~E13.5, when XY and XX germ cells undergo mitotic arrest and meiotic entry, 
respectively.  This marks the end of the PGC stage of germline development20. 
While the origin of human primordial germ cells (hPGCs) is less clear than that of mPGCs, 
hPGC specification likely occurs between week 2-3 of development when direct studies on 
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these early postimplantation human embryos are impractical21, 22. Differences in PGC 
specification mechanisms might be envisaged since regulation of pluripotency and early 
postimplantation development in mouse and human differ (see Box 1 for details). Specified 
hPGCs are first observed during the early fourth week (~E24)23, 24 in the extraembryonic yolk 
sac wall near the allantois, which is an equivalent location to that of mPGCs at ~E8. Thereafter, 
hPGCs migrate and colonize the incipient genital ridge by the early sixth week (~E37)24. 
Gonadal hPGCs (also known as gonocytes (XY) or oogonia (XX)) remain proliferative until 
around the tenth week, when they asynchronously enter mitotic quiescence in male embryos 
and meiotic prophase in female embryos.  
Until recently, our understanding of human germline development was mainly based on 
extrapolation from mice, supplemented with sporadic immunohistochemistry studies in humans. 
However, advances in mouse germline biology, particularly over the past 15 years, have 
informed our more recent breakthroughs on the mechanism of hPGC development. Here, we 
review the signalling principle and gene regulatory network for human and mouse PGC 
specification. Emerging evidence shows that there are critical mechanistic differences between 
human and mouse PGC specification that were not anticipated from studies in mice. We also 
review the latest advances in germline epigenetic reprogramming in the two species, with 
particular focus on DNA demethylation and chromatin reorganization. These events have 
impacts on subsequent germline development and the totipotent state at fertilization, as well as 
on the transmission of genetic and epigenetic information to subsequent generations.  
 
Mammalian germline induction 
Induction of germ cell fate by extrinsic signals 
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There are two basic modes for germline formation in metazoans: “preformation” and 
“epigenesis”25. In C.elegans, Drosophila and Xenopus, maternally inherited determinants 
(known as germ plasm) are exclusively allocated to prospective germ cells following fertilization 
(i.e. preformation)26. However, in mammals and many other animals, germ cells are induced in 
competent cells by extrinsic signals during embryogenesis (i.e. epigenesis)1, 27, 28.  
In mice, PGC specification occurs in response to complex signalling crosstalk within the egg-
cylinder just before gastrulation1, 29, 30 (Figure 2a). BMP signals produced in the extraembryonic 
ectoderm (ExE) and proximal visceral endoderm (VE) are essential for mPGC induction in the 
posterior proximal epiblast at E6.25. Genetic ablation of Bmp2/4/8b31-33 or downstream 
signalling components (e.g. Alk234 and Smad1//4/535-37) in mice results in loss or reduction of 
mPGCs. In a comprehensive signalling study, Ohinata et al2 found that both BMP2 and BMP4 
can dose-dependently induce PRDM1-postive mPGCs in isolated epiblasts cultured ex vivo, 
with BMP4 being the more potent inducer. In addition, the authors reported that mutants of 
Wnt3 and its downstream signalling transducer β-Catenin, fail to form mPGCs regardless of 
BMP signalling1, 30. WNT3 is expressed in the posterior VE and epiblast at E5.5-E6.5 and is 
known to induce primitive streak genes essential for gastrulation38. While these mesodermal 
genes are initially induced in mPGC precursors, they become repressed in specified E7.5 
mPGC to maintain germ cell identity.  However, one of the WNT3 target genes, mesodermal 
factor T (or Brachyury), is unexpectedly required for mPGC specification30. Whilst PRDM1-
positive mPGC precursors are formed in T knockout embryos, they fail to sustain PRDM1 
expression and do not upregulate the mPGC specifier PRMD14. In contrast, overexpression of 
T alone in WNT3 mutants without cytokines is sufficient to induce PRDM1 and PRDM14 
expression by activating their putative enhancers. Thus, some mesodermal factors induced by 
WNT3/β-CATENIN signalling during gastrulation indeed promote germ cell fate. How precisely 
BMPs and WNT3 cooperate to induce both germ cells and mesoderm at the posterior epiblast is 
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still unclear. It is possible that the high BMP dosage at the most proximal posterior epiblast 
favours germ cell induction over mesoderm formation (Figure 2a). Although the role of nodal 
signalling has not been investigated, it is likely critical for mPGC specification as Bmp4 and 
Wnt3 are absent in Nodal-deficient embryos39. 
The signalling mechanism for PGC specification and gastrulation in non-rodent mammals, which 
develop as a planar embryonic disc instead of an egg cylinder as in rodents, is less clear. To 
extrapolate patterning in mice to other mammals, some embryologists proposed a flattened 
model which unfolds the egg cylinder into a planar embryonic disc40, 41 (see Figure 2b for 
details). The predicted signalling pattern in this model is roughly in line with patterns recently 
observed in rabbit peri-gastrulation planar embryos42, 43. In rabbits, both BMP2 and BMP4 are 
expressed as a ring-like domain in the peripheral epiblast and trophoblast, as well as in the 
nascent mesoderm42. In contrast, BMP4 and WNT3 antagonists, CER1 and DKK1 respectively, 
are expressed in the anterior hypoblast43. These signals likely restrict rabbit PGC induction and 
gastrulation to the posterior epiblast where PRDM1-positive putative PGCs and the primitive 
streak are observed42. There is currently little information on WNT3 and BMP8a expression in 
non-rodent mammals. Notably, similar BMP signalling pattern is also observed in pig embryos 
around the time of PGC induction44. Overall, despite differences in development, comparative 
biology suggests that BMP signalling is very likely a conserved signal for PGC specification in 
mammals, including humans45-47 (see below).  
 
Germline competence and in vitro PGC induction 
In mouse embryos, only a few cells in the posterior proximal epiblast acquire the PGC fate while 
the rest of the epiblast cells differentiate into the ectoderm, endoderm and mesoderm. However, 
ex vivo culture suggests that most of the pregastrulation E5.5-E6.25 epiblast cells are germline 
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competent1, 48. Initial efforts to reconstitute PGC specification in vitro resulted in limited success, 
mainly due to the lack of germline competent pluripotent states (Box 2). Taking in vivo 
development into account, Hayashi et al49 developed a two-step model to reconstitute mPGC 
specification in vitro (Figure 3a). Accordingly, preimplantation epiblast-like naïve mouse 
embryonic stem cells (mESCs)50, 51 are first differentiated into postimplantation epiblast-like cells 
(mEpiLCs)49. Upon exposure to BMP4 and defined supporting cytokines, mEpiLCs efficiently 
give rise to mPGC-like cells (mPGCLCs) that resemble in vivo mPGCs. Remarkably, these cells 
undergo gametogenesis and yield functional sperm and eggs after transplantation into gonads 
of neonatal/adult mice49, 52. This in vitro mPGCLC specification system has since been used to 
address mechanistic aspects of mPGC development (see later).  
Until recently, a robust in vitro PGC induction model was not available for humans. Human 
embryonic stem cells (hESCs) grown under conventional condition (Box 2) are believed to be in 
a “primed” pluripotent state, and exhibit low germline competence45, 53. However, a number of 
recent studies have proclaimed establishment of naive hESC culture conditions (for review, 
see54, 55). These studies also led to a distinct hESC type which self-renew under a four inhibitors 
(4i) condition (consists of TGFβ , FGF2 and leukemia inhibitory factor (LIF), together with 
inhibitors of ERK1/2, GSK3β, JNK and p38)56. Remarkably, hESCs cultured in 4i condition 
directly (without any pre-treatment) respond to BMP2/4, and undergo hPGC-like cell (hPGCLC) 
specification with high efficiency after 4-5 days (up to ~50%) (Figure 3b), as opposed to <5% 
efficiency with conventional hESCs45. These hPGCLCs exhibit a transcription profile that is 
globally similar to in vivo week 7 hPGCs. Notably, hPGCLCs and hPGCs share a unique gene 
expression profile, including PGC genes (e.g. PRDM1, TFAP2C and NANOS3), pluripotency 
genes (e.g. NANOG, POU5F1 (or OCT4), TFCP2L1 and KLF4), lineage specifiers (e.g. SOX17, 
GATA4 and TEAD4) and cell surface markers (e.g. CD38 and ALPL)45. These hPGCLCs likely 
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represent pre-migratory hPGCs, which have just initiated global epigenetic reprogramming, 
including global DNA demethylation45 and imprint erasure57.  
Several recent studies shows that hESC cultured in 4i condition exhibit a transcriptome that is 
more similar to conventional primed hESCs than to the naïve pluripotent preimplantation 
epiblast cells in the blastocyst58-60. The key distinction between hESC cultured in 4i and 
conventional conditions is the upregulation of early mesodermal genes (e.g. T, MIXL1, FOXA2, 
RUNX1 and PDGFRA) in the former, which might signify their competence for germ cell fate45. 
Consistently, two subsequent studies also demonstrate that cells bearing early mesodermal 
characters have enhanced capability for hPGCLC specification47, 61. In one of the reports, 
human induced pluripotent stem cells (hiPSCs) cultured under a preformulated commercial 
medium are induced into “insipient mesoderm-like cells” (hiMeLCs), which are germline 
competent and can give rise to PRDM1- and TFAP2C-positive hPGCLCs with up to 40% 
efficiency when exposed to BMP2/447 (Figure 3b). Similar to hESCs cultured in 4i medium, 
hiMeLCs exhibit expression of early mesodermal genes. In comparison to mouse pluripotent 
stem cells, hiMeLCs are considered to be at a developmental state in between that of pre-
gastrulating mEpiLCs and anterior primitive streak-like mEpiSCs47, 62 (Box 2). These 
independent studies suggest that hPGCs may originate at the onset of gastrulation from 
mesodermal precursors, rather than pre-gastrulation epiblast as in mice (Figure 3). In fact, 
specification of PGCs from mesoderm is a well-conserved mechanism in many organisms, 
including the basal insect cricket28 and the tetrapod ancestor axolotl27. Even in mice where 
mPGCs are induced prior to mesoderm formation, mesodermal factors, like T, play an essential 
role in regulating expression of key mPGC specifiers30.  
 
Acquisition of germline competence 
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How do cells acquire competence for germline fate?  Recent mouse studies reveal dynamic 
epigenetic changes during the transition from naïve mESCs to germline competent mEpiLCs63-
66. In particular, regulatory elements of postimplantation epiblast genes accumulate active 
enhancer marks H3K4me1 and H3K27ac in mEpiLCs while naïve pluripotency-associated 
enhancers lose their active states63. Promoters of developmental genes and germ cell specifiers 
(e.g. PRDM1 and PRDM14) become bivalently marked by H3K4me3 and H3K27me3, and are 
considered poised for activation upon mPGC specification64. The mechanistic link between 
germline competence and the rewired enhancer and promoter epigenetic landscape in mEpiLCs 
requires further investigations. Unlike mEpiLCs and hiMeLCs, hESCs cultured in 4i condition 
can self-renew while retaining germline competence seemingly indefinitely. This state is also 
reversible as it can be gained or lost by switching between 4i and conventional conditions45. 
These properties make them tractable models to elucidate the mechanistic basis of germline 
competence in humans. 
 
Regulatory Network for mPGC specification 
A tripartite transcription factor network 
The signals that induce mPGC specification also engender gastrulation and mesoderm 
formation. This accounts for the expression of early mesoderm genes, such as T, Eomes, 
Hoxa1 and Hoxb1, in PRDM1-positive mPGC precursors67, 68. Although T initially facilitates 
mPGC specification30, somatic genes, in general, need to be repressed in nascent mPGCs in 
order to maintain germ cell identity. Establishment of mouse germ cell fate is governed primarily 
by PRDM1, PRDM14 and TFAP2C, which are upregulated in mPGC precursors at E6.25-6.752-4 
(Figure 4a). Knockout of any one of Prdm1, Prdm14 and Tfap2c in mice impairs mPGC 
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specification2-4, 69. These embryos exhibit reduced numbers of AP-positive mutant mPGCs, 
which are lost between E8.5 to E12.5. A common phenotype observed amongst these cells is 
the de-repression of mesodermal genes2, 4, 67, 70, suggesting that the three transcription factors 
together are essential for suppressing the somatic programme. PRDM1 and PRDM14 are also 
responsible for upregulation of germ cell and pluripotency genes, and initiation of epigenetic 
reprogramming. The latter is evident from the repression of EHMT1 which promotes H3K9me2 
erasure, and other factors that promote DNA methylation, including Dnmt3a, Dnmt3b and Uhrf1 
(see later)2, 3, 67. Importantly, overexpression of any two of the three transcription factors, or 
PRDM14 alone, is sufficient to induce mPGCLCs from competent mEpiLCs5, 7. Thus, PRDM1, 
PRDM14 and TFAP2C form a tripartite transcription factor network that is necessary and 
sufficient for mPGC induction.  
In line with other transcription factors, PRDM1, PRDM14 and TFAP2C are independently 
involved in diverse developmental processes. For instance, PRDM1 is a well known 
transcriptional repressor involved in lymphocyte differentiation71 while PRDM14 maintains 
pluripotency in ESCs70, 72, 73. TFAP2C is expressed in a variety of tissues and plays an essential 
role in trophectoderm specification74, 75. Genome-wide DNA binding maps reveal that PRDM1, 
PRDM14 and TFAP2C cooperate in an intricate manner to upregulate germ cell and 
pluripotency genes, repress somatic fate, initiate migration and reset the epigenome5, 6. In 
particular, PRDM1 predominantly binds to promoters5, 64 whilst PRDM14 is enriched in distal 
regulatory elements72. TFAP2C binds to targets of both PRDM1 and PRDM14 to activate or 
repress target genes5, 6. Since none of these factors demonstrate histone-modifying activities, 
they likely modulate transcriptional activities by recruiting epigenetic modifiers. PRDM14 was 
shown to interact with SUZ12, a polycomb repressive complex 2 (PRC2) component, to confer 
repressive H3K27me3 in mESCs73. However, two recent interactome studies show that 
PRDM14, instead of interacting with PRC2 component, forms a complex with ETO family 
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protein CBFA2T2 (or MTGR1), which is known to recruit histone deacetylases (HDACs) for 
gene silencing76, 77. Deletion of Cbfa2t276, 77, or interruption of the interaction between CBFA2T2 
and PRDM1476, mimics the effect of Prdm14 knockout in pluripotency maintenance and mPGC 
specification. Similarly, PRDM1 has been reported to interact with histone modifiers, including 
HDAC2, KDM1A, EHMT1 and PRMT578.  
 
Pluripotency factors in mPGC development 
Re-expression of pluripotency genes is a hallmark of mPGC development. Apart from POU5F1 
which is expressed throughout mPGC induction79, 80, other pluripotency factors, such as SOX267, 
81 and DPPA368, 82, are transiently repressed in epiblast/mPGC precursors and re-expressed in 
specified mPGCs at ~E7.25-E7.75. Consistent with the presence of pluripotency factors, 
mPGCs can readily de-differentiate into pluripotent embryonic germ cells (EGCs) under 
appropriate culture conditions83-85. 
Due to their requirement for preimplantation development, the involvement of pluripotency 
factors in mPGC specification has been unclear. Notably, conditional knockout/knockdown of 
Pou5f186, Nanog87, 88, Sox289 and Sall490 after specification result in loss of mPGCs through 
apoptosis or proliferation defects, highlighting the importance of pluripotency factors in mPGC 
maintenance. Making use of the mPGCLC induction model, we recently found that 
overexpression of NANOG alone in mEpiLCs, but not of POU5F1 or SOX2, can induce germ 
cell fate66. Unexpectedly, NANOG induces mPGCLC by direct activation of Prdm1 and Prdm14 
enhancers independently of BMP4. On the other hand, loss of Nanog impairs the efficiency of 
mPGCLC induction by BMP4. Since NANOG is expressed in the posterior epiblast where 
mPGCs are specified from, BMP signalling and NANOG might act cooperatively to induce germ 
cell fate in vivo. 
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A distinct hPGC specification network 
Critical role of endodermal factor SOX17 
Immunohistochemistry and recent RNA sequencing studies have shown that hPGCs retain a 
core set of genes essential for mouse germ cell development21, 22, 57, 91. This includes 
specification genes (e.g. PRDM1 and TFAP2C), germline-specific genes (NANOS3, DND1, 
DAZL and DDX4) and pluripotency factors (e.g. NANOG, POU5F1 and DPPA3). Nonetheless, 
careful comparison of mouse and human PGC expression profiles has revealed some key 
differences. For example, hPGCs lack the core pluripotency gene SOX292 but express ICM-
associated naïve pluripotency factors TFCP2L1 and KLF457. Furthermore, hPGCs express 
several lineage specifiers, which are absent in mPGCs, including trophectoderm regulator 
TEAD457 and endoderm regulator SOX1793.  
Among these differences, the absence of SOX2 and the presence of the endoderm specifier 
SOX17 are particularly noteworthy, since SOX2 is required for mPGC proliferation89 whilst 
SOX17 is dispensable for mPGC specification94. Even though both SOX17 and SOX2 belong to 
the SRY-related HMG-box transcription factor family, it is unlikely that SOX17 is simply a 
replacement for SOX2 in hPGCs, as these proteins belong to different subfamilies. SOX2, 
together with SOX1 and SOX3, belongs to the SOXB1 subfamily which has critical roles in 
pluripotency maintenance and neuroectoderm differentiation95. On the other hand, SOX17, 
together with SOX7 and SOX18, are classified as SOXF subfamily and are essential for 
endoderm differentiation96, fetal hematopoiesis97 and cardiovascular development98. Moreover, 
SOX17 cannot replace SOX2 in pluripotency maintenance and somatic cell reprogramming99. In 
fact, overexpression of SOX17 in mESCs induces exit of pluripotency and endoderm 
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differentiation100. In contrast, the closely related SOXB1 subfamily members, SOX1 and SOX3, 
can replace SOX2’s functions as a regulator of pluripotency and neuron differentiation95, 99. It is 
important to note that all SOXB1 members (i.e. SOX1, SOX2 and SOX3) are absent in 
hPGCs57, 92, suggesting that SOXB1-mediated functions are excluded in hPGCs.  
Surprisingly, SOX17 is amongst the first transcription factors to be upregulated during the 
specification of hPGCLC from competent hESCs45. Knockout of SOX17 in competent hESCs 
abolishes hPGCLC specification and this can be rescued by SOX17 overexpression. PRDM1 
expression is compromised in the absence of SOX1745, indicating that it acts downstream of 
SOX17. As in mice2, 69, loss of PRDM1 during hPGCLC specification results in downregulation 
of some hPGC genes, and de-repression of developmental genes45, 47, 57. Expression of key 
transcription factors, such as SOX17, TFAP2C and POU5F1, are mildly affected. Interestingly, 
the loss of PRDM1 in humans causes upregulation of endoderm genes (e.g. GATA4, GATA6 
and FOXA2)45, indicating that PRDM1 plays a role in repressing endodermal genes, which could 
be induced by SOX17101. Overall, PRDM1 is important for initiation of the germ cell programme 
and repression of somatic genes that are presumably induced by upstream BMP signalling and 
SOX17 (Figure 4b). PRDM1 may also play a role in initiation of global DNA demethylation by 
repressing the de novo methyltransferase DNMT3B47, 57.  
 
Potential partnership of SOX17 and POU5F1 
How can SOX17, a transcription factor with diverse roles in development of somatic lineages, 
be involved in establishment of human germ cell fate? SOX proteins modulate transcriptional 
activities with a partner transcription factor which binds to an adjacent DNA sequence98. It is 
likely that SOX17 regulates transcription at distinct sets of loci by interacting with different 
partners in different cellular contexts. Pluripotency factor POU5F1 is one of the known 
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interaction partners of SOX17102. In both human and mouse ESCs, it is well established that 
POU5F1 acts in conjunction with SOX2 to maintain pluripotency95. Interestingly, POU5F1 
“switches” partners from SOX2 to SOX17 during primitive endoderm (PE) differentiation from 
mESCs103. As a result, SOX17-POU5F1 binds to enhancers of endoderm genes and apparently 
activates their expression for PE fate. Notably, one of the targets of SOX17-POU5F1 in mice is 
Prdm1103. Since POU5F1 is highly expressed throughout hPGCLC induction from competent 
hESCs45, it is possible that similar switching of partners might occur for establishment of human 
germ cell fate. A possible scenario is that both germ cell genes and endodermal genes are 
poised for SOX17-POU5F1 activation in human germline competent cells. One of the potential 
downstream targets, PRDM1, may then act in tandem to activate germ cell genes and repress 
endodermal genes and other somatic genes. If so, the rapid downregulation of SOX2 upon 
hPGCLC specification and its continual absence in hPGCs might be necessary to allow SOX17-
POU5F1 interaction and avoid neuroectoderm differentiation. Correct dosage of SOX17 and 
POU5F1 may also be important for hPGC fate, as both transcription factors exhibit dose-
dependent action in directing differentiation100, 104. Intriguingly, while PRDM1 represses 
endodermal factors in hPGCs, it is also expressed in PE where the endodermal genes are 
expressed, indicating that the repressive role of PRDM1 is context-dependent. Another SOX 
family protein SOX15 is highly expressed in both human and mouse PGCs47, 91. SOX15 is the 
sole member of SOXG group and is co-expressed in mESCs with SOX2105. SOX15 physically 
interacts with POU5F1105 and shares some common targets with SOX2 in mESCs106. However, 
the loss of Sox15 in mESCs does not affect maintenance of pluripotency. In addition to SOX 
family proteins, trophectoderm specifiers TFAP2C and TEAD4, pluripotency factors NANOG, 
TFCP2L1 and KLF4, all show early expression in hPGCLCs45, 91. Their potential functions and 
combinatorial effects in hPGCLC specification merit further investigations. 
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The paradox of PRDM14 in hPGC development 
Since PRDM14 is indispensable and sufficient for PGC specification in mice3, 7, 70, its role in 
hPGC is of particular interest. PRDM14 is strongly expressed in germline competent hESCs but 
is rapidly downregulated during hPGCLC induction by BMP2/445. Thereafter, PRDM14 becomes 
modestly expressed in specified hPGCLCs. As PRDM14 plays an integral role in the core 
pluripotency circuit in hESCs107, 108, its rapid suppression is probably necessary for exit of 
pluripotency. Indeed, overexpression of PRMD14 in hESCs upon random differentiation 
prevents the upregulation of genes of the three germ layers (e.g. T, MIXL1, GATA4 and 
PAX6)108. Partial knockdown experiments suggest that PRDM14 may not be required for 
hPGCLC specification61, although additional evidence is required to verify this result. In mice, 
PRDM14 also facilitates global DNA demethylation by repressing de novo methyltransferases 
Dnmt3a and Dnmt3b70, but its role in hPGC reprogramming is unclear. Gonadal hPGCs 
undergoing global DNA demethylation exhibit low and heterogeneous expression of PRDM1491 
with predominant localization in the cytoplasm45. Moreover, even in the presence of nuclear 
PRDM14, conventional hESCs exhibit very strong expression of DNMT3A/3B and hESC 
genome remains highly methylated57. Thus, cumulative evidences suggest that PRDM14 may 
have a less prominent role in hPGC development. Intriguingly, when transfected into mouse 
cells, human PRDM14 can however substitute for mouse PRDM14 to rescue defects of Prdm14 
knockout mESCs109. This suggests that the two orthologs are functionally conserved and that 
the behaviour of human PRDM14 may hinge on the precise interacting partners and cellular 
contexts. The paradox of PRDM14 in human germline development remains to be fully 
addressed.  
Overall, the critical role of SOX17 in hPGC specification and the apparent diminished role for 
PRDM14 suggest a clear divergence in the mechanisms for PGC specification and the initiation 
of epigenetic reprogramming between humans and mice. It will be of interest to establish 
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whether SOX17-mediated germline induction is a general mechanism conserved amongst non-
rodent mammals which develop as planar embryonic disc. 
 
Resetting the germline epigenome 
In mammals, global epigenetic reprogramming occurs during preimplantation development, and 
in the early germline. The former resets the zygotic epigenome for naïve pluripotency (reviewed 
in110, 111), while the latter erases parental epigenetic memories and facilitates gametogenesis. 
Here, we focus on epigenetic resetting in the mouse and human early germline, and discuss its 
potential impact on germ cell maintenance, differentiation and epigenetic inheritance. 
 
Genome-wide DNA demethylation 
In mice, PGCs are specified from the postimplantation epiblast, which is hypermethylated and 
primed for lineage differentiation. To reset the epigenome, mPGCs undergo genome-wide DNA 
demethylation11, X-chromosome reactivation14-17 and chromatin modification reorganization19 as 
they migrate and colonize the genital ridge from E8.0 to E13.5 (Figure 5). During this time, 
global CpG methylation levels drop from ~70% in the epiblast to unprecedented low levels of 
~4% in E13.5 mPGCs9, 112. As a result, almost all genomic features, including imprint control 
regions, become hypomethylated. Methylation is then re-established in a sex-specific manner 
after E13.5 in males and after birth in females110. 
The current view is that global DNA demethylation in the germline is primarily achieved through 
a passive mechanism. Shortly after mPGC specification, PRDM1 and PRDM14 repress 
expression of de novo DNA methyltransferases DNMT3A and DNMT3B, as well as UHRF15, 67, 
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a recruitment factor of DNMT1 that is essential for the maintenance of DNA methylation113. As a 
result, both maintenance and de novo methylation activities are apparently repressed, enabling 
replication-coupled DNA demethylation when mPGCs proliferates9, 114-116.  
Recent evidence suggests that enzymatic conversion of 5-methylcytosine (5mC) to 5-
hydroxymethylcyotsine (5hmC) also plays a part in demethylation, especially for imprints, which 
are protected from demethylation until mPGCs settle in the genital ridge at ~E9.5-E10.5. Ten-
eleven translocation enzymes (TET1, TET2 and TET3) oxidize 5mC to 5hmC and downstream 
derivatives, which can subsequently be enzymatically removed and replaced by unmethylated 
cytosine, or be diluted passively during replication117. Concurrent with TET1 and TET2 
upregulation at E9.5-E11.5, transient global increase of 5hmC coupled with reduction of 5mC is 
observed in mPGCs10, 118. Nonetheless, knockout studies in mice suggest that a large extent of 
germline DNA demethylation can still occur independently of TET1 and TET2119-121. However, 
TET1 and TET2 are required for efficient erasure of imprints119, 120 and demethylation of meiotic 
gene promoters for germ cell differentiation121.  
Recently, three independent studies showed that the overall DNA demethylation dynamics in 
hPGCs is similar to that in the mouse germline (Figure 5a)57, 91, 122. At week 5, migratory hPGCs 
in the hindgut already exhibit low 5mC levels compared to neighbouring soma57. As hPGCs 
settle in the genital ridge, DNA methylation levels drop to a minimum of ~4.5% by week 857, 91. 
Interestingly, germ cells of both sexes (isolated by hPGC surface marker c-KIT) stay 
hypomethylated at week 1991, around 9 weeks after the start of meiotic entry in females and 
mitotic quiescence in males. Immunohistochemistry studies show that this c-KIT positive 
population represents rare germ cells that retain hPGC characteristics, while the majority of 
germ cells have differentiated into c-KIT-negative prespermatogonia or oogonia123-125. While 
human oogonia likely remain hypomethylated before birth as in mice, it remains unclear whether 
the more advanced male germ cells at week 19 have begun remethylation126.  
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As in mPGCs, DNA demethylation in hPGCs is associated with the repression of UHRF1, 
DNMT3A and DNMT3B. Furthermore, hPGCs exhibit transient high levels of 5hmC, which is 
coupled with TET1 and TET2 upregulation57. Notably, the majority of imprints are already 
demethylated when hPGCs arrive at the genital ridge57, indicating earlier imprint erasure 
dynamics in humans as compared with mice.  
 
Chromatin reorganization safeguards the germline  
DNA methylation is an important epigenetic silencer, which modulates gene expression and 
maintains genome stability in mammalian cells127. Loss of DNA methylation in somatic lineages 
causes derepression of retrotransposons, proliferation defects and cell death. Notably, 
hypomethylated human and mouse PGCs remain proliferative without signs of global gene or 
retrotransposon activation. Similar to PGCs, Dnmt1/Dnmt3A/Dnmt3B triple knockout mESCs 
can self-renew in the absence DNA methylation128, although they perish upon differentiation. 
Recent studies in mESCs suggest that global DNA demethylation triggers reorganization of 
repressive chromatin modifications to repress retrotransposons and maintain genome 
stability129, 130. In fact, DNA demethylation in mPGCs is also accompanied by global chromatin 
modification reorganization18, 19. Apart from depletion of H3K9me2, repressive H3K27me3 and 
H2A/H4R3me2s are both enriched during the course of mPGC development, while H3K9me3 is 
retained predominantly at pericentric heterochromatin (Figure 5a)19, 131. In addition to modulating 
gene expression, these marks have been implicated in the repression of retrotransposons in 
mPGCs132. For instance, loss of H3K9 methyltransferase SETDB1 in mPGCs causes depletion 
of H3K9me3 and H3K27me3 in endogenous retroviruses (ERVs)133. This is associated with 
depression of many ERVs (e.g. intracisternal A particle (IAP)) and reduced numbers of male 
germ cells. Likewise, loss of arginine methyltransferase PRMT5 in mPGCs results in male and 
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female sterility that is associated with depletion of H2A/H4R3me2s and upregulation of LINE1 
and IAP elements in mPGCs134. Global reorganization of repressive histone modifications is 
also observed in hPGCs, albeit with slightly different dynamics (Figure 5a). Thus, it is likely that 
one of the purposes of germline chromatin reorganization is to safeguard genome integrity while 
PGCs undergo DNA demethylation to unprecedentedly low levels (Figure 5b and 5c).  
Notably, naïve pluripotency genes (e.g. TFCP2L1 and KLF4) are expressed in human ICM, 
naïve hESCs and hPGCs, all of which exhibit a globally hypomethylated genome57, 60, 135, 136. It is 
tempting to speculate that naïve pluripotency factors may have roles in facilitating genome-wide 
DNA demethylation and/or safeguarding the globally hypomethylated genome. However, the 
comprehensive extent of DNA demethylation seen in hPGCs (down to 4% average CpG 
methylation in contrast to 30-40% in ICM and naïve hESCs) suggests that additional factors are 
in place to facilitate robust DNA demethylation. 
 
“Escapees” from global DNA demethylation 
Despite global DNA demethylation, some genomic loci, referred to as “escapees”, remain 
methylated in human and mouse PGCs9-11, 57. In both species, the vast majority of escapees are 
associated with retrotransposable elements9-11, 57, 91. In particular, evolutionarily young and 
potentially hazardous retrotransposons, such as IAP in mice137 and SVA in humans57, remain 
relatively highly methylated, which may contribute to their repression. Escapees are also found 
in pericentric satellite repeats57 and in subtelomeric regions11. Retention of DNA methylation in 
these regions may maintain chromosome stability and ensure proper chromosome alignment 
and segregation during mitosis. Notably, a minority of escapees are single copy sequences9-11. 
In humans, “repeat-poor” escapees are widely distributed in the genome, including promoters, 
gene bodies and enhancers57. Some escapees are associated with genes that are expressed in 
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the brain and participate in neuronal differentiation, while some are found in ubiquitously 
expressed genes, like circadian regulator CSNK1D57. The functions of these repeat-poor 
escapees, particularly those found in regulatory regions, remain to be determined.  
 
Potential mechanisms for escapee methylation 
The existence of escapees suggests that DNA methylation pathways are not completely 
repressed in PGCs. In both human and mouse PGCs, DNMT1 remains strongly expressed in 
the nucleus, whilst DNMT3A, DNMT3B and UHRF1 are not detectable57, 114, 122. While DNMT1 is 
generally regarded as a maintenance DNA methyltransferase, recent studies suggest that 
DNMT1 exhibits de novo methylation activity on unmethylated DNA in vivo and in vitro138. Given 
these evidences, it is possible that DNMT1 acts independently of UHRF1 to confer and/or 
maintain methylation at escapee loci. Human escapees are enriched for H3K9me3 and KAP1 
binding sites57, suggesting that DNMT may be targeted to the escapees via the KAP1/KRAB-
ZFP co-repressor complex. The zinc finger domain of KRAB-ZFPs binds to specific DNA 
sequences while the KRAB domain interacts with KAP1, which recruits histone deacetylases, 
histone methyltransferase SETDB1 and/or DNMT1 for heterochromatin formation139. In humans, 
there are approximately 400 KRAB-ZFPs, presumably with different DNA binding specificity, 
and hence different targets. For instance, ZFP91 and ZFP93 have been shown to target and 
repress human SVAs and L1PAs retrotransposons respectively140, while ZFP57 maintains 
methylation at imprinted loci141, 142. Many KRAB-ZFPs are highly expressed in hPGCs and may 
be involved in recruiting DNMT1 to confer DNA methylation at retrotransposon and single copy 
escapee loci57. Parallel mechanisms, like PIWI-piRNA pathways, may also take part in 
methylation of retrotransposons57, 91, 143. Notably, PRDM9 (also known as ZNF899) has been 
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shown to be essential for meiotic recombination144, suggesting that KRAB-ZFPs may also 
perform other critical functions during germ cell development.   
 
Epigenetic inheritance via DNA methylation 
The inheritance of non-genetic information through the mammalian germline has received 
considerable attention in recent years145-147. Since DNA methylation is stably heritable through 
cell division, it is a candidate for the transmission of epigenetic information through the germline. 
Indeed, a classical example of epigenetic inheritance involving DNA methylation is the 
transmission of genomic imprints148, 149. Parent-of-origin-specific DNA methylation is established 
at imprint control regions (ICR) concurrently with global remethylation during gametogenesis 
and is transmitted to the zygote following fertilization. Although imprints are maintained during 
global demethylation in the preimplantation embryo and persist in somatic cells, they are erased 
during germline reprogramming and re-established in each generation. Imprinting is therefore 
an intergenerational epigenetic inheritance phenomenon. Indeed, the comprehensive nature of 
germline and, to a lesser extent, DNA demethylation during preimplantation development would 
reduce the likelihood of transgenerational epigenetic inheritance (TEI) through DNA 
methylation147. Moreover, a large portion of the genome becomes fully remethylated during 
gametogenesis, representing another barrier to TEI. However, recent studies have identified 
some single copy and retrotransposon loci that can escape both waves of demethylation9, 11, 57 
and some of these loci remain partially methylated in gametes57. It is possible that methylation 
at these escapee loci might be susceptible to environmental factors and such epigenetic 
information could potentially be transmitted to subsequent generations with phenotypic 
consequence.  
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Inheritance of environment-induced metabolic and behavioural traits have been reported in 
mammals, where most phenotypes last for one to two generations (reviewed by145, 146). For 
instance, male mice exposed to in utero undernutrition yield offspring that exhibit obesity and 
glucose intolerance150. Although there are locus-specific DNA methylation changes in sperm of 
exposed males, differential methylation is not detected in the offspring. More recently, it was 
shown that paternal diet does not have consistent effects on the sperm methylome151 while 
small RNA in sperm may contribute to intergenerational inheritance of diet-induced metabolic 
disorders152, 153. Taken together, recent evidence indicates that DNA methylation is less likely to 
be the primary mechanism for environment-induced epigenetic inheritance, but this cannot be 
entirely excluded at present. Moreover, it remains possible that some retrotransposon 
escapees, such as IAP in mice and SVA in humans, may give rise to metastable epialleles, 
which are vulnerable to environmental influence. This is exemplified by Agouti viable yellow 
mice and Axin-fused mice, in which IAP insertion to the vicinity of the Agouti or Axin-fused 
genes causes ectopic gene expression and TEI phenotypes145. 
 
Conclusions and Perspectives 
The divergence of human and mouse occurred ~60 million years ago. Since then, mice have 
acquired a unique egg-cylinder structure for peri-gastrulation development154, while humans and 
a number of other mammals develop as a planar embryonic disc. The germline of both species 
arise during this period of developmental divergence. Recent breakthrough in in vitro hPGCLCs 
specification and direct studies on in vivo hPGCs has provided extensive information on human 
germline development. Whilst BMP signalling appears to be a conserved pathway for human 
and mouse germ cell induction, the competent state and gene regulatory network for PGC 
specification have diverged between the two species. On the other hand, the extent and the 
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dynamics of epigenetic reprogramming in human and mouse PGCs appear similar, albeit not 
identical. The mechanism of initiation of the epigenetic programme however may differ due to 
the involvement of SOX17 as a key germline specifier, and as yet unclear contribution of 
PRDM14. Notably, both germlines feature some single copy and retrotransposon demethylation 
escapees, which may be important for genome stability and could have potential for epigenetic 
inheritance.   
In the light of these discoveries, new questions emerge that merit further investigation. What is 
the molecular basis for germline competent states? How do transcription factors with diverse 
functions in different lineages act combinatorially to specify and maintain germ cell fate? What 
triggers epigenetic reprogramming in hPGCs? How are “escapees” targeted and do they have 
functional significance in the germline? Since functional studies in human are not possible, 
further advances in in vitro hPGC development are required to address some of these 
questions. Under current conditions, hPGCLCs do not progress beyond pre-migratory stage and 
therefore do not undergo comprehensive epigenetic reprogramming or upregulate meiotic 
genes45, 47. Development of in vitro conditions that enable robust differentiation of hPGCLC 
towards later gonadal stages and beyond will be essential. Indeed, a recent report shows that 
haploid mouse spermatid-like cells can be derived from mESCs using an entirely in vitro step-
wise protocol155. These haploid cells apparently yield fertile offspring after injection into oocytes, 
albeit at a low frequency (~2%). While observations in this study remain to be reproduced, it has 
raised the prospects for in vitro reconstitution of meiosis and gametogenesis in humans. 
Mice have been and will remain a valuable model for mammalian development. However, 
studies on human germline development suggest that not all observations in mice can be 
faithfully extrapolated to humans. Indeed, the mechanism for neuroectoderm specification has 
also diverged between men and mice156. In view of these differences, studies on non-rodent 
mammals, such as rabbits42, pigs44 and non-human primates, in combination with in vitro human 
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models, will provide insights on the mechanism of PGC specification and other early cell fate 
decision in humans.  
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Box 1: Divergence of early embryo development in mice 
and humans  
After fertilization, human and mouse zygotes both undergo a series of cleavage divisions (see 
the figure) and cell fate decisions, leading to the formation of blastocysts (reviewed in157, 158). 
The blastocyst is composed of a pluripotent inner cell mass (ICM) and an outer trophectoderm 
(TE) (see the figure). The ICM subsequently segregates into preimplantation epiblast and 
hypoblast (also known as primitive endoderm). The epiblast primarily develops into the embryo 
proper while the TE and the hypoblast gives rise to extraembryonic tissues, including the 
placenta and the yolk sac. Whilst human and mouse preimplantation development are 
morphologically similar, there are notable differences in developmental timing, gene expression, 
signalling requirement for pluripotency and lineage segregation58, 159. For instance, although 
human and mouse preimplantation epiblasts share the expression of some naïve pluripotency 
factors (e.g. TFCP2L1, KLF4 and TBX3), ESRRB and KLF2 are present in mice but not in 
humans58, 160. Furthermore, TGFβ signalling pathway components (e.g. NODAL, GDF3 and 
TGFBR1) are highly expressed in the human epiblast58. Inhibition of this pathway in blastocysts 
downregulates the core pluripotency factor NANOG in human epiblast but has no detectable 
effect in mice, indicating that regulation of pluripotency differs between human and mouse. 
Human and mouse embryos become structurally distinct following implantation. As the mouse 
blastocyst implants at ~E4.5, the pluripotent epiblast cells become polarized and transform into 
a cup-shaped epithelium40, 161, while the TE-derived extra-embryonic ectoderm (ExE) forms an 
inverted cup on top. Concurrently, the hypoblast develops as the visceral endoderm (VE) and 
envelops the epiblast and ExE. These result in the formation of an egg cylinder with proximal-
distal and anterior-posterior axes157. At E5.5, the distal VE (DVE) thickens and forms a 
specialized signalling region, and migrates proximal-anteriorly and become the anterior VE 
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(AVE). Reciprocal signalling interactions between the epiblast, the ExE and the VE lead to 
gastrulation at the posterior epiblast at E6.5, where the primitive streak emerges and gives rise 
to mesoderm and definitive endoderm (reviewed in29).  
Humans, and possibly all non-rodent mammals, exhibit a planar structure during peri-
gastrulation period162. Following implantation at E8-9, the epiblast moves away from the 
trophoblast, creating the amniotic cavity. The postimplantation epiblast and the underlying 
hypoblast flatten into a round bilaminar embryonic disc, which is sandwiched between the fluid-
filled amniotic cavity and the yolk sac (formerly the blastocoel). Cells originated from the epiblast 
and the hypoblast form the linings of the amniotic cavity (amnion epithelium) and the yolk sac 
(yolk sac epithelium), respectively. At around E16, gastrulation commences and the primitive 
streak is formed at the posterior end of the embryonic disc and extends halfway across the 
epiblast towards the anterior region. The proliferating epiblast cells along the streak undergo 
epithelial-mesenchymal transition and migrate to the space between the epiblast and PE, giving 
rise to the mesoderm layer. The ingressing epiblast cells also replace hypoblast cells to become 
definitive endoderm. This process sees the bilaminar embryonic disc transforming into a 
trilaminar disc, which contains the three germ layers for lineage specification. 
In mice, PGC specification occurs at the posterior epiblast prior to gastrulation2. This is 
dependent on pluripotent state49 and intricate signalling interaction between embryonic and 
extraembryonic tissues in the egg cylinder1, 30 (Figure 2a). Less is known about PGC origin and 
peri-gastrulation patterning in planar embryos of humans and other non-rodent mammals. The 
divergence in pluripotency regulation and embryonic structure between rodents and other 
mammals may culminate in mechanistic differences for germline establishment.  
 
28 
 
Box 2: Pluripotent states and initial attempts of in vitro 
PGC induction  
Pluripotency, a transient state during early embryonic development, can be maintained in vitro 
as self-renewing pluripotent stem cells (for review, see54, 55, 163). In mice, naïve pluripotent cells 
in the ICM of E3.5-E4.5 blastocysts give rise to mouse embryonic stem cells (mESCs) that are 
traditionally maintained under fetal calf serum and leukemia inhibitory factor (LIF) in vitro164, 165. 
Serum/LIF mESCs can contribute to all somatic lineages and the germline when introduced 
back into blastocysts. Since serum contains various undefined signalling molecules, serum/LIF 
mESCs are in metastable states and cycle in and out of naïve pluripotency163. On the other 
hand, mouse epiblast stem cells (mEpiSCs) are traditionally derived with Activin A and FGF2 
from E5.5-E6.5 mouse postimplantation epiblasts that are poised for lineage differentiation166, 
167. Although mEpiSCs express core pluripotency factors Pou5f1, Nanog and Sox2, they 
upregulate somatic markers (e.g. Otx2, Eomes, Foxa2 and T) and lack expression of naïve 
pluripotency genes (e.g. Prdm14, Tbx3 and Zfp42 (also known as Rex1)). They can contribute 
to chimaeric embryos when grafted into postimplantation epiblast62, 168 but exhibit limited 
contribution when injected into preimplantation blastocysts166, 167. Thus, mEpiSCs are 
considered to be in a “primed” pluripotency state. 
Putative germ cells are generated at a very low frequency by spontaneous differentiation of 
serum/LIF mESCs in vitro169, 170. The fact that in vivo mPGCs are specified from ~E6.0 
postimplantation epiblasts led to the speculation that postimplantation-epiblast derived mEpiSCs 
might be germline competent. However, mEpiSCs also demonstrate very limited capacity for 
mPGCLC specification (up to 1.5%)171. Recent studies show that mEpiSCs acquire properties 
more similar to anterior primitive streak cells than to pre-gastrulating epiblasts62, which might 
explain the low germline competence in these cells. To achieve robust mPGCLC induction, an 
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intermediate entity in between naive mESCs and primed mEpiSCs is required. Recently, 
Hayashi et al. established such a germline competent epiblast-like state in vitro49 (Figure 3a).  
Human ESCs (hESCs) can also be derived from blastocyst culture172. Although hESCs and 
mESCs have similar embryonic origins, they exhibit different morphology, gene expression 
patterns and signalling requirements for maintenance of pluripotency173. For example, while 
mESCs are dependent on BMP and LIF signallings, conventional hESCs require FGF and 
TGFβ signallings174. Instead, hESCs share similar properties with mEpiSCs and are considered 
to be in a “primed” pluripotency state173. However, there are some notable differences between 
hESCs and mEpiSCs. For example, hESCs express naïve pluripotency genes PRDM14 and 
ZFP42, which are absent in mEpiSCs, and both factors are essential for maintenance of hESC 
pluripotency107, 175. Thus, conventional hESCs likely represent a distinct pluripotent state which 
has characteristics of both naïve mESCs and primed mEpiSCs.  
Previous studies showed that conventional hESCs can differentiate into hPGCLCs at a low 
frequency (up to 5%) by spontaneous differentiation, which can be promoted by BMP 
signalling46, 53, 176. The low germ cell induction capacity suggests that hESCs do not represent a 
germ cell competent state. Recent evidence indicates that cells with early mesoderm 
characteristics exhibit high competence for human germ cell fate45, 47, 61 (Figure 3b). 
 
Figure legends 
Figure 1: Cycle of human germline development 
After fertilization, the zygote develops into the blastocyst which contains pluripotent 
preimplantation epiblast cells. These cells give rise to all lineages in the embryo proper, 
including the germline. As the blastocyst implants into the uterine wall, it develops a bilaminar 
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embryonic disc and later undergoes gastrulation to form the ectoderm, mesoderm and 
endoderm germ layers (see also Box 1). Human primordial germ cells (hPGCs) are likely 
specified around the time of gastrulation (~E17) although the exact origin of hPGC in the 
embryo remains unknown. At week 4, hPGCs locate at the yolk sac wall close to the allantois 
and later migrate through the hindgut to the developing genital ridges. Migratory hPGCs 
undergo genome-wide epigenetic reprogramming, including global DNA demethylation, to erase 
imprints and other somatic epigenetic memories. During fetal development and adulthood, 
gonadal germ cells undergo meiosis and gametogenesis to differentiate into sperm and eggs. 
Concurrently, the genome is remethylated and acquires appropriate epigenetic signatures for 
the generation of a totipotent zygote upon fertilization. 
 
Figure 2: Signalling for mammalian germline induction. 
a | At the time of mouse primordial germ cell (mPGC) specification and gastrulation, the embryo 
forms an egg cylinder with anterior-posterior (A-P) and proximal-distal (P-D) axes (left panel). 
BMP4 from the extraembryonic ectoderm (ExE), together with BMP2 and WNT3 from the 
posterior visceral endoderm (VE), induce a few PRDM1-positive mPGC precursors at the most 
posterior proximal epiblast, the site with highest levels of BMP signals1, 30. The anterior VE 
(AVE) expresses antagonists of BMP (e.g. CER1 and LEFTY1) and WNT (e.g. DKK1), which 
prevents mPGC and mesoderm induction at the anterior epiblast1. Smad2 and FoxH1 mutant 
embryos, which lack a functional AVE, exhibit ectopic induction of PRDM1-positive cell in the 
anterior epiblast1. BMP8b expressed in the ExE may have a role in restricting the AVE domain 
from extending to the posterior epiblast1. The expression patterns of key signals for mPGC 
specification are illustrated on the right panel. 
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b | A hypothetical signalling model for PGC induction in humans and other non-rodent 
mammals. The mouse E6.5 embryo is transformed into a planar structure (left panel)40, 41 which 
corresponds to ~E17 trilaminar human embryo (right panel). In this model, the cup-shaped 
mouse epiblast and VE are unfolded into the upper and the lower layer of an embryonic disc 
respectively, with the nascent mesoderm sitting in between the two layers at the posterior end 
(left panel). The ExE becomes the structural equivalent of amnion epithelium/peripheral epiblast 
in humans. The extraembryonic VE in mice would become the yolk sac epithelium. As a result, 
the proximal-distal axis in the egg cylinder becomes a peripheral-central axis. Projection of key 
PGC specification signals predicts that BMP4 and BMP8b would be expressed as a ring-like 
domain that surrounds the epiblast, while the posterior hypoblast/epiblast would be the site of 
BMP2 and WNT3 signals. Inhibitory signals from the anterior hypoblast would restrict PGC 
induction to the posterior epiblast/nascent mesoderm, where BMP dosage is the highest. It is 
important to note that human and mouse postimplantation development are fundamentally 
different and this model serves to translate signalling patterns in mice for comparison with that 
in non-rodent mammals. 
 
Figure 3: Reconstitution of mouse and human PGC specification in vitro. 
a | In mice, the E3.5-E4.5 preimplantation epiblast can give rise to naïve self-renewing 
embryonic stem cells (mESCs) under a basal culture condition that consists of leukemia 
inhibitory factor (LIF), GSK3β inhibitor and ERK1/2 inhibitor (referred as 2i/LIF)50. Priming of 
naïve mESCs with Activin A and FGF2 for 2 days yields epiblast-like cells (mEpiLCs), which are 
transcriptionally similar to E5.75 pre-gastrulating epiblast49. Like its in vivo counterpart, mEpiLCs 
are germline competent and can robustly give rise to mouse PGC-like cells (mPGCLCs) in 
response to high dosage of BMP4 with BMP8B, LIF, stem cell factor (SCF) and epidermal 
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growth factor (EGF). Transcriptome and epigenetic profiles of day 6 mPGCLCs are globally 
similar to in vivo E9.5 migratory mPGCs. XY mPGCLCs can differentiate into sperm after 
transplantation into the seminiferous tubules of W/Wv neonatal mice which are sterile and lack 
endogenous germ cells49. The mPGCLC-derived spermatozoa can yield healthy fertile offspring 
following intracytoplasmic sperm injection into oocytes. Similarly, XX mPGCLCs can mature into 
functional oocytes following aggregation with female gonadal somatic cells and transplantation 
into the ovarian bursa of adult mice52.  
b | Despite their origin from blastocyst, conventional human embryonic stem cells (Conv 
hESCs) cultured under FGF2-containing medium are considered to be in a primed pluripotent 
state similar to that in postimplantation epiblast and are not germline competent (see also Box 
2). Conv hESCs can reversibly adapt to a recently reported “4i” condition, which consists of 
TGFβ, FGF2 and leukemia inhibitory factor (LIF), together with inhibitors of ERK1/2, GSK3β, 
JNK and p3856. Self-renewing 4i hESCs exhibit expression of early mesoderm genes and are 
competent for human PGC-like cell (hPGCLC) formation in the presence of BMP2/4 and other 
cytokines (up to 50% efficiency)45. Alternatively, human induced pluripotent stem cells (hIPSCs) 
cultured under feeder-free condition with an preformulated commercial medium can give rise to 
hPGCLCs at ~20% efficiency in response to BMP447. When cultured under Activin A and 
GSK3β inhibitor for 2 days, these hIPSCs can differentiate into incipient mesoderm-like cells 
(hiMeLCs) which exhibit enhanced competence for hPGCLC formation (up to 40% efficiency). 
hPGCLCs generated from 4i hESCs and hiMeLCs share similar transcriptome and likely 
represent pre-migratory stage hPGCs47, 57. 
 
Figure 4: Gene regulatory network models for mouse and human PGC specification. 
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a | In mice, BMP-SMAD and WNT3-β-CATENIN signalling induces expression of PRDM1 and 
PRDM14, as well as mesoderm genes in mPGC precursors30. The precise mechanism for initial 
upregulation of PRDM1 at E6.25 remains unclear, but it is known that mesodermal factor T is 
required for sustaining PRDM1 expression and triggering PRDM14 expression30. Maintenance 
of PRDM1 and PRDM14 expression are mutually interdependent3, 70. PRDM1 and PRDM14 
induces TFAP2C expression, and together, the three transcription factors form a core 
specification network (yellow eclipse)5, 7 to upregulate germ cell and pluripotency genes, repress 
mesoderm genes, temporarily inhibit cell proliferation18, and initiate epigenetic reprogramming 
and migration.  
b | In humans, SOX17 is critical for hPGC specification and is upstream of PRDM1 
expression45. PRDM1 represses SOX17-induced endoderm genes, BMP/WNT-induced 
mesoderm genes and other somatic genes. Together, SOX17 and PRDM1 establish the human 
germ cell programme, while the role of TFAP2C and PRDM14 in hPGC specification remains to 
be clarified. Notably, SOX2 is absent in hPGCs. BMP signalling177 and PRDM1178 may 
contribute to rapid downregulation of SOX2 during hPGC specification. It is unclear whether 
BMP-SMAD signalling directly activates SOX17 or indirectly through activation of other 
transcription factors. The role of WNT3-β-CATENIN signalling and mesodermal factor T in 
hPGC specification remains unknown but might be less significant. 
Arrows and blunt-ended arrows depict positive and negative regulation respectively. Dotted 
lines indicate postulated regulations.   
 
Figure 5: Epigenetic reprogramming in mouse and human PGCs. 
a | Genome-wide DNA demethylation occurs in mPGCs during the onset of migration and early 
settlement at the genital ridge (~E7.5 to E13.5). Concurrently, mPGCs exhibit global chromatin 
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modification reorganization. In particular, H3K9me2, a repressive chromatin modification 
associated with silenced genes, becomes globally depleted. Since there is intimate crosstalk 
between H3K9me2 and DNA methylation pathways179, loss of H3K9me2 in mPGCs may 
facilitate or be a consequence of global DNA demethylation. On the other hand, H3K9me3 
levels remain high at pericentric heterochromatin-, while repressive H3K27me3 level become 
progressively enriched globally. H2A/H4R3me2s is transiently increased from E8.5 to E10.5, 
along with nuclear localization of the arginine methyltransferase PRMT5131, 134. The overall 
global epigenetic reprogramming dynamics in the human germline is similar to that in mPGCs, 
but with subtle differences. Notably, coupled loss of 5mC and H3K9me2 is also observed in 
hPGCs. However, H3K27me3 is only transiently enriched in hPGCs during migration and 
becomes low after arrival at the genital ridge57, 180. H2A/H4R3me2s levels stay constant 
throughout hPGC development (Tang WWC, unpublished data).  Dotted lines indicate 
postulated dynamics in hPGCs. 
b | Germline DNA demethylation erases parental epigenetic memories and drives germ cell 
differentiation. Allele-specific methylation at imprinting control regions (ICRs) are erased in 
PGCs and re-established in a sex-specific manner later in development. In XX PGCs, loss of 
DNA methylation and repressive H3K27me3 at the inactivated X-chromosome (labelled Xi) lead 
to X reactivation. This ensures each oocyte contains an active X-chromosome (labelled Xa) for 
early embryonic development after fertilization. In somatic cells, some germ cell-specific meiotic 
and genome defence genes (e.g. DDX4, DAZL, SYCP3, PIWILs and KRAB-ZFPs) are silenced 
by promoter DNA methylation. Demethylation of their CpG island (CGI) promoters in PGCs 
facilitates germ cell differentiation and maintains genome stability.  
c | Despite global loss of DNA methylation, both evolutionary old (e.g. LINE-L2) and young (e.g. 
LTR-IAP in mice and LTR-HERVK in humans) retrotransposons remain repressed in PGCs. 
Repressive chromatin modifications are likely redistributed/retained at repetitive sequences to  
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safeguard genome stability. Notably, some evolutionarily young retrotransposons (e.g. LTR-IAP 
in mice and SVA in humans) and pericentromeric satellite repeats remain partially methylated 
which may contribute to their repression.  
 
Glossary 
Totipotency 
The ability of a cell to give rise to all cell types (both embryonic and extraembryonic) of an 
organism. 
 
Epiblast 
Pluripotent cells derived from the inner cell mass of a blastocyst that give rise to all lineages of 
the embryo proper. 
 
Allantois 
A membranous sac that develops from the mesoderm (in mice) or hindgut endoderm (in 
humans) during early embryonic development. Allantois contributes to the formation of the 
umbilical cord and placenta. 
 
Gastrulation 
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The developmental process in which the three germ layers (i.e. ectoderm, mesoderm and 
definitive endoderm) of the embryo are formed.  
 
Primitive streak 
A structure in the posterior end of the embryo where epiblast cells ingress to form the 
mesoderm and definitive endoderm. Formation of the primitive streak is the first visible sign of 
gastrulation. 
 
Nodal Signalling 
A signal transduction pathway that is essential for the formation of mesoderm and endoderm 
and axis determination in vertebrates. Nodal signalling is activated by transforming growth factor 
beta (TGF-β) family factors Activin and Nodal and transduced by SMAD2/3. 
 
Trophoblast 
The outermost layer of extraembryonic tissues that attaches the embryo to the uterine wall and 
forms the placenta. 
 
Pluripotent states 
Pluripotency refers to the ability of a cell to differentiate into any cell of the three germ layers in 
the embryo proper. The preimplantation epiblast represents a “naïve” pluripotent state, while the 
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postimplantation epiblast (poised for lineage differentiation) represents a “primed” pluripotent 
state. 
 
Inner cell mass (ICM) 
A compact mass of cells located at the embryonic pole of the blastocyst. ICM gives rise to the 
epiblast and the hypoblast, which forms the embryo proper and the yolk sac respectively. 
 
Lineage specifiers 
Transcription factors that direct competent cells to differentiate into a specific cell lineage. 
 
Genomic imprinting 
An epigenetic phenomenon that results in monoallelic gene expression in a parent-of-origin-
dependent manner. 
 
Bivalent promoter 
A promoter simultaneously marked by both activating H3K4me3 and repressive H3K27me3 
histone modifications. Genes with bivalent promoters are considered “poised” for activation 
when exposed to appropriate extrinsic signals.  
 
Retrotransposons 
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DNA elements that can amplify themselves in the genome. During the process of 
retrotransposition, retrotransposon DNA is transcribed into RNA, then reverse transcribed into 
DNA, followed by insertion into a new genomic site. 
 
KRAB-zinc finger proteins 
The largest individual family of transcriptional repressors in mammals. KRAB-ZFPs contain DNA 
binding C2H2 zinc fingers and a Krüppel-associated box (KRAB) domain which interacts with 
KAP1 corepressor complex for epigenetic silencing. 
 
Transgenerational epigenetic inheritance 
Transmission of epigenetic information through the germline that affects phenotypic traits in 
more than one generation without changes in DNA sequence. 
 
Highlighted references 
Ohinata, Y. et al. A signaling principle for the specification of the germ cell lineage in mice. Cell 
137, 571-84 (2009). 
A comprehensive signalling study which shows that BMP/pSMAD and WNT3 signallings 
are indispensable for mPGC specification from postimplantation epiblast during a 
restricted time-window.  
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Vincent, S.D. et al. The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for 
early axis formation but is required for specification of primordial germ cells in the mouse. 
Development 132, 1315-25 (2005). 
Ohinata, Y. et al. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436, 
207-13 (2005). 
The above papers show that Prdm1 is the earliest lineage-restricted marker of mPGC and 
that it is indispensable for mPGC specification. 
 
Yamaji, M. et al. Critical function of Prdm14 for the establishment of the germ cell lineage in 
mice. Nat Genet 40, 1016-22 (2008). 
This paper shows that Prdm14 is critical for the upregulation of pluripotency genes and 
the initiation of epigenetic reprogramming during mPGC specification. 
 
Weber, S. et al. Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell 
maintenance. Biol Reprod 82, 214-23 (2010). 
This paper shows that Tfap2c, together with Prdm1, repress mesodermal gene 
expression during mPGC specification. 
 
Hayashi, K., Ohta, H., Kurimoto, K., Aramaki, S. & Saitou, M. Reconstitution of the mouse germ 
cell specification pathway in culture by pluripotent stem cells. Cell 146, 519-32 (2011). 
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This paper shows robust in vitro induction of mPGCLCs from ground-state mESCs via a 
postimplantation epiblast-like state.  
 
Magnusdottir, E. et al. A tripartite transcription factor network regulates primordial germ cell 
specification in mice. Nat Cell Biol 15, 905-15 (2013). 
Nakaki, F. et al. Induction of mouse germ-cell fate by transcription factors in vitro. Nature 501, 
222-6 (2013). 
The above papers show that overexpression of Prdm1, Tfap2c and/or Prdm14 is 
sufficient for induction of mPGC fate. 
 
Nady, N. et al. ETO family protein Mtgr1 mediates Prdm14 functions in stem cell maintenance 
and primordial germ cell formation. Elife 4 (2015). 
Tu, S. et al. Co-repressor CBFA2T2 regulates pluripotency and germline development. Nature 
(2016). 
The above papers show that co-repressor CBFA2T2 is a novel interactor of PRDM14 in 
regulation of pluripotency and mPGC specification. 
 
Irie, N. et al. SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate. Cell 160, 253-
68 (2015). 
This paper shows robust in vitro induction of hPGCLCs from germline competent hESCs 
and illustrates that SOX17 is essential for hPGC specification. 
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Guibert, S., Forne, T. & Weber, M. Global profiling of DNA methylation erasure in mouse 
primordial germ cells. Genome Res 22, 633-41 (2012). 
Seisenberger, S. et al. The dynamics of genome-wide DNA methylation reprogramming in 
mouse primordial germ cells. Mol Cell 48, 849-62 (2012). 
Hackett, J.A. et al. Germline DNA demethylation dynamics and imprint erasure through 5-
hydroxymethylcytosine. Science 339, 448-52 (2013). 
The above papers reveal the detailed genome-wide DNA demethylation dynamics in 
mPGCs. 
 
Walter, M., Teissandier, A., Perez-Palacios, R. & Bourc'his, D. An epigenetic switch ensures 
transposon repression upon dynamic loss of DNA methylation in embryonic stem cells. Elife 5 
(2016). 
This paper shows that repressive chromatin modifications repress retrotransposons and 
safeguard genome stability during chemical-induced global loss of DNA demethylation in 
mESCs. 
 
Tang, W.W. et al. A Unique Gene Regulatory Network Resets the Human Germline Epigenome 
for Development. Cell 161, 1453-67 (2015). 
Guo, F. et al. The Transcriptome and DNA Methylome Landscapes of Human Primordial Germ 
Cells. Cell 161, 1437-52 (2015). 
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Through high quality RNA-Seq and BS-Seq analyses, the above papers reveal the 
transcriptional network and epigenetic reprogramming dynamics in hPGCs isolated from 
human embryos.  
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